Search results
Regeneron Bulls, Bears Clash: Will Biotech Get Eylea Mojo Back?
Investor's Business Daily· 8 months agoRegeneron Pharmaceuticals is the IBD Stock of the Day as the biotech giant trades near an all-time...
Declining Stock and Solid Fundamentals: Is The Market Wrong About Regeneron Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 1 year agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Regeneron Pharmaceuticals' estimated fair value is US$1,903 based on 2 Stage Free Cash...
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) closed at $587.28 in the latest trading session, marking a +0.2% move from the...
Regeneron (REGN) Is Up 3.97% in One Week: What You Should Know
Zacks via Yahoo Finance· 5 months agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 4 months agoRegeneron Pharmaceuticals (NASDAQ:REGN) has had a great run on the share market with its stock up by...
Regeneron (REGN) Recently Broke Out Above the 20-Day Moving Average
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) is looking like an interesting pick from a technical perspective, as the company...
Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround
Zacks via Yahoo Finance· 2 months agoRegeneron (REGN) has become technically an oversold stock now, which implies exhaustion of the heavy...
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its...
Simply Wall St. via Yahoo Finance· 2 weeks agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 4.9% over the past month. Since the market...